Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2011, Article ID 985085, 9 pages
http://dx.doi.org/10.4061/2011/985085
Review Article

Targeting Glycogen Synthase Kinase-3β for Therapeutic Benefit against Oxidative Stress in Alzheimer's Disease: Involvement of the Nrf2-ARE Pathway

1Department of Neurobiology, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland
2Department of Pathology, The University of Melbourne, Melbourne, VIC 3010, Australia
3School of Pharmacy, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland
4Department of Oncology, Kuopio University Hospital, P.O. Box 1777, 70211 Kuopio, Finland

Received 29 December 2010; Accepted 1 March 2011

Academic Editor: Peter Crouch

Copyright © 2011 Katja Kanninen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Katja Kanninen, Anthony R. White, Jari Koistinaho, and Tarja Malm, “Targeting Glycogen Synthase Kinase-3β for Therapeutic Benefit against Oxidative Stress in Alzheimer's Disease: Involvement of the Nrf2-ARE Pathway,” International Journal of Alzheimer’s Disease, vol. 2011, Article ID 985085, 9 pages, 2011. https://doi.org/10.4061/2011/985085.